Published in Cancer Weekly, February 28th, 2006
According to recent research from Sweden, "The aim of this study was to validate sentinel node biopsy for axillary staging after the initial learning phase, and to analyze factors associated with false-negative biopsies. Some 675 patients, who had standard sentinel node biopsy followed by level I and II axillary clearance in 1 of 20 hospitals in Sweden and were operated on by 36 different surgeons, were recruited prospectively. The overall detection rate...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.